EMHTF - Emerald Health Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
3.1100
-0.2000 (-6.04%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.3100
Open3.2500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range3.0600 - 3.3400
52 Week Range1.4800 - 5.0000
Volume538,346
Avg. Volume522,349
Market Cap438.501M
Beta (3Y Monthly)2.50
PE Ratio (TTM)N/A
EPS (TTM)-0.1290
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE3 days ago

    New Cannabis Stocks Gunning for the Top-THC Therapeutics Inc.

    HENDERSON, NV / ACCESSWIRE / March 20, 2019 / With cannabis in the news and investors becoming more and more hungry for the next big winner in the industry, we decided to highlight a couple that could ...

  • GlobeNewswire3 days ago

    Emerald Health Therapeutics Applauds Government of Canada for Proposing Amendment to Cannabis Excise Tax in Federal Budget

    OTCQX: EMHTF) applauds the Government of Canada for proposing to amend the excise tax calculation for cannabis in the federal budget announced yesterday. The implementation of the proposed revision announced in the federal budget would result in the calculation of the excise duty of ingestible cannabis and hemp products being based on the quantity of THC in the products, as opposed to the current tax set in relation to the product volume.

  • ACCESSWIRE4 days ago

    These Four Marijuana Stocks are Heating Up on Tuesday

    CORAL GABLES, FL / ACCESSWIRE / March 19, 2019 / One of the longest-running ways to reach the top of the marijuana stock market has been for companies to invest in growing cannabis. Taking that into consideration, there are companies that are seeing impressive gains as a result of their focus being the improvement of products for consumers in the cannabis market. Leafbuyer Technologies Inc (OTC:LBUY), Auxly Cannabis Group Inc (OTCQX:CBWTF), Emerald Health Therapeutics Inc (EMHTF), and HEXO Corp (NYSE American: HEXO, TSX: HEXO) represent 4 marijuana stocks looking strong on Tuesday.

  • GlobeNewswire5 days ago

    Emerald Health Therapeutics Appoints Vice President, Communications and Stakeholder Relations

    OTCQX:EMHTF) announced today that Allan Rewak has been appointed Vice President, Communications and Stakeholder Relations, effective April 15, 2019. Prior to joining Emerald, Mr. Rewak was the Executive Director at the Cannabis Council of Canada (C3), Canada’s national industry association for cannabis, cultivators and processors. For his work, the Financial Post named him “One of the 20 Power Players Setting Down Roots in the Cannabis Industry”.

  • GlobeNewswire9 days ago

    Emerald Health Therapeutics Continues to Grow Sales with First Cannabis Shipment to Ontario Cannabis Retail Corporation

    OTCQX:EMHTF) has fulfilled its first purchase order of cannabis from Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (“OCS”). “As we scale up production in our wholly-owned, premium indoor growing facility, Verdélite, and our large-scale, state-of-the-art joint venture greenhouse operation, Pure Sunfarms, we are consistently meeting our supply commitments of Emerald-branded adult-use cannabis in British Columbia and Newfoundland Labrador, and we are now prepared to provide the same service to the Ontario Cannabis Retail Corporation and other provinces,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald. Currently, Emerald’s cannabis supply is provided primarily through its 88,000 sq. ft. Verdélite indoor facility in Saint Eustache, Quebec, and through Pure Sunfarms, its 50%-owned 1.1 million sq. ft. greenhouse facility in Delta, British Columbia.

  • OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference
    PR Newswire10 days ago

    OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

    OTCQX and OTCQB Companies Featured at 2019 ROTH Conference NEW YORK , March 13, 2019 /PRNewswire/ --  OTC Markets Group Inc . (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, ...

  • GlobeNewswire11 days ago

    Cannabis Stocks That Could See Significant Growth in Retail

    Cannabis sales have been soaring since legalization in Canada but there's a lot more to come as the industry continues to change. Here are some of the hottest cannabis stocks right now that are positioning themselves to take advantage of the fast-growing retail market. Westleaf has been making a name for itself in the industry as it looks to become a dominant force in the retail market.

  • ACCESSWIRE12 days ago

    Four Marijuana Stocks Gaining Speed On Monday

    CORAL GABLES, FL / ACCESSWIRE / March 11, 2019 / It's quite astounding that the marijuana stock market continues to receive so much attention despite the nascent nature of the cannabis industry. Having said that, the cannabis industry has seen a boom in excitement this past year as a result of lawmakers pushing for legislation in support of marijuana legalization. Global Consortium Inc (OTC:GCGX), Aphria Inc (APHA), Emerald Health Therapeutics Inc (EMHTF), and Innovative Industrial Properties Inc (IIPR) are 4 marijuana stocks heating up on Monday.

  • GlobeNewswire12 days ago

    Emerald Health Therapeutics Sees Pure Sunfarms Licensed for 1.03 Million Square Feet of Cannabis Cultivation; Full Planting Targeted for End of April

    OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms Corp. (“Pure Sunfarms”), received from Health Canada its seventh amendment to its cultivation license for its 1.1 million square foot greenhouse in Delta, BC. The additional approximately 206,000 square feet of growing area in the fourth and final quadrant of the greenhouse brings Pure Sunfarms’ total licensed cannabis production area to approximately 1.03 million sq. ft. in 16 grow rooms. “Pure Sunfarms is now licensed across all its growing areas and we congratulate their team for this significant accomplishment,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald. “With Emerald’s 50% stake in one of the largest fully operational cannabis production facilities in the world, we expect to realize significant economic value from Pure Sunfarms.

  • GlobeNewswire16 days ago

    Emerald Health Therapeutics’ Licensed Endo Product Wins Taste For Life’s 2019 Essentials Supplement Award in the U.S.

    OTCQX:EMHTF)  today announced that its joint venture partner’s, (Emerald Health Bioceuticals or “EHB”), Endo Bliss, won Taste For Life’s 2019 Essentials Supplement Award, which recognizes the most outstanding natural supplements in health and wellness in the U.S. Emerald will launch the Endo product line in Canada in 2019 through its joint venture, Emerald Health Naturals (“EHN”), which secured Canadian distribution rights for this product line that was developed to support the body’s endocannabinoid system (“ECS”), but which does not contain cannabis.

  • Jefferies Echoes Cramer’s Views on the Cannabis Beverage Market
    Market Realist24 days ago

    Jefferies Echoes Cramer’s Views on the Cannabis Beverage Market

    Why Jim Cramer Likes Canopy Growth(Continued from Prior Part)Recurring themeJim Cramer has mentioned that alcoholic beverage companies are at risk due to growth in the cannabis sector (MJ).Jefferies echoed Cramer’s viewOn February 25, another

  • ACCESSWIRE26 days ago

    4 Marijuana Stocks Heating Up On Monday (2/25/19)

    CORAL GABLES, FL / ACCESSWIRE / February 25, 2019 / The marijuana stock market has been incredibly active over the last few months with companies in the cannabis industry reaping the benefits of all the excitement. There are several factors that have resulted in the current state of the cannabis industry, the first of which relating to legislation put forth by progressives to legalize marijuana. Second of all, whereas companies in different industries rarely collaborate, cannabis companies have worked with companies across a variety of sectors to share the benefits of cannabis products with consumers, no matter the field.

  • Jefferies Initiates Coverage of CGC, TRST, ACB, OGRMF, and More
    Market Realist26 days ago

    Jefferies Initiates Coverage of CGC, TRST, ACB, OGRMF, and More

    Jefferies Initiates Coverage of CGC, TRST, ACB, OGRMF, and MoreJefferies initiates coverage on cannabisJust last week, we saw Seaport Global initiate coverage on some of the big cannabis players in the industry. Early this morning, yet another firm

  • ACCESSWIRElast month

    Four Pot Stocks Looking To Close Out a Strong Week

    CORAL GABLES, FL / ACCESSWIRE / February 21, 2019 / The 2019 year has already shown a significant amount of upward momentum for the marijuana stock market. A key reason for this tidal shift of positive energy is due to the fact that companies throughout the industry are progressing because many states in the U.S., as well as Canada, have passed legislation in favor of legalizing cannabis. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Emerald Health Therapeutics Inc (EMHTF) (TSX-VEMH), CannTrust Holdings Inc (OTC PINK: CNTTF), and KushCo Holdings Inc (KSHB) are 4 pot stocks that could test this week's highs.

  • ACCESSWIRElast month

    How the Government Helped Create a $3 to $300 Stock Windfall, and Could Do it Again

    The Human Genome Project changed the scientific landscape completely, spurring major public and private investment into understanding human DNA. A newer government-backed effort called the BRAIN Initiative seeks to map the human brain, similar in scope to the Human Genome project. This initiative will fund major progress in neurology in the same way, and it coincides with a recent surge in investor interest in new technology targeting the nervous system.

  • ACCESSWIRElast month

    Watch These Marijuana Stocks Push Their Limits

    Generations earlier, many people believed cannabis to be a harmful substance and demanded that the federal government keep it out of the hands of consumers, but as we've come to understand, cannabis has a myriad of health benefits and is nothing to be afraid of. Over the past few years, cannabis companies have continued to release new products with medical cannabis for the purpose of improving the quality of treatment options available for consumers in the healthcare space. ), Aphria Inc (APHA), Emerald Health Therapeutics Inc (EMHTF) (EMH.V) and Tilray Inc (TLRY) are four companies that could test February highs.

  • GlobeNewswirelast month

    Emerald Health Therapeutics Launches 88,000 Square Foot State-of-the-Art, Fully-Integrated Indoor Facility and Verdélite Brand in Québec

    OTCQX: EMHTF) today announced the launch of Verdélite Sciences Inc. ("Verdélite"), a wholly-owned, Québec-based production subsidiary licensed by Health Canada. Formerly known as Agro-Biotech, Verdélite currently produces high-grade dried cannabis for medical and adult-use purposes. Emerald is nearing completion of its over $100 million investment to secure and expand its multi-purpose facility to 88,000 square feet and enable the complete cycle of indoor cultivation, product development and automated packaging of cannabis products.

  • ACCESSWIRElast month

    Cannabis Consumable Plays on the Rise

    HENDERSON, NV / ACCESSWIRE / February 19, 2019 / Below are several cannabis companies who produce consumer products that look ripe for a bull run. One we think has explosive growth potential is Real Brands, ...

  • This Suspect Pot Stock Is Really Getting Its Act Together
    Motley Foollast month

    This Suspect Pot Stock Is Really Getting Its Act Together

    Will this top-tier marijuana grower finally get some respect from Wall Street?

  • GlobeNewswirelast month

    Emerald Health Therapeutics Announces Completion of Pure Sunfarms CAD$20 Million Credit Facility with Bank of Montreal and Farm Credit Canada

    OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms Corp. (“Pure Sunfarms”), has entered into a credit agreement with Bank of Montreal (“BMO”) as agent and lead lender and Farm Credit Canada (“FCC”) as lender (together with BMO, the “Lenders”) in respect of a CAD$20 million secured non-revolving term loan (the “Credit Facility”). Pure Sunfarms intends to use the funds available under the Credit Facility to finance the final costs of converting its 1.1 million square foot greenhouse for cannabis production, the vast majority of which was completed in January of this year. The funds available under the Credit Facility may also be used for general corporate purposes.

  • GlobeNewswirelast month

    Emerald Health Therapeutics Announces Pure Sunfarms’ Selection to Supply Ontario Cannabis Store

    OTCQX:EMHTF) today announced its cannabis joint venture, Pure Sunfarms Corp. (“Pure Sunfarms”), has through a competitive process been selected by and entered into a supply agreement with the Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (“OCS”), to supply the OCS with Pure Sunfarms-branded cannabis products for the non-medical market in the Province of Ontario.

  • ACCESSWIRElast month

    Watch These Marijuana Stocks Enjoy A Boost From Today's Headlines

    As we see an increase in agricultural technology being used to increase the yield, and quality, of cannabis products, companies across the space will have greater access to inventory to distribute their products. Considering the fact that legal marijuana is becoming a reality in a large portion of the United States, Canada, and abroad, investors that have historically written off cannabis companies, are now flocking in droves with excitement. Nabis Holdings (INNPF) (NAB), Emerald Health Therapeutics Inc (EMHTF) (EMH.V), Green Growth Brands Inc (GGBXF), and The Supreme Cannabis Company (SPRWF) are four cannabis companies worth keeping on your radar on Thursday.

  • GlobeNewswire2 months ago

    Emerald Health Therapeutics Secures Proprietary Extraction Technology and  Extraction Capabilities in Agreement with Indena

    OTCQX:EMHTF) has entered into a license with Indena S.p.A. (“Indena”) of Milan, Italy, bearing certain exclusivity rights in Canada to use Indena’s cannabidiol (“CBD”) extraction technology, and contract manufacturing services for CBD extraction. In addition, Emerald has obtained exclusive use of Indena’s proprietary Phytosome® technology for the purpose of developing novel cannabinoid-based products with superior utility, subject to a minimum volume agreement.

  • ACCESSWIRE2 months ago

    These 4 Marijuana Stocks Could Surpass Investor Expectations

    CORAL GABLES, FL / ACCESSWIRE / February 4, 2019 / Marijuana stocks have managed to become one of the hottest topics in the news over the course of the past few years. The fact of the matter is that previously conceived notions on cannabis are being replaced by favorable public opinions supporting all possible uses of marijuana, namely as a means of treatment for patients suffering from a myriad of ailments. Global Consortium Inc (GCGX), Emerald Health Therapeutics Inc (EMHTF) (EMH.V), Trulieve Cannabis Corp (OTC PINK: TCNNF), and OrganiGram Holdings Inc (OGRMF) are four pot stocks looking to remain on high this month.

  • GlobeNewswire2 months ago

    Emerald Health Therapeutics Announces Discharge of Litigation

    OTCQX:EMHTF) announced today that its wholly-owned subsidiary, Verdélite Sciences Inc. (“Verdélite”), which operates a 75,000 square foot indoor cannabis cultivation facility in St.-Eustache, Quebec, has entered into a release, discharge and transaction agreement settling all claims made by Pivot Pharmaceuticals Inc. (“Pivot”) against Verdélite and its former shareholders, as described in Emerald’s most recent MD&A. The claims relate to a non-binding letter of intent which Verdélite and its former shareholders had previously entered into with Pivot with respect to a potential sale of Verdélite.